The transmission of Mycobacterium tuberculosis in high burden settings (Q38729690)

5 September 2017

The transmission of Mycobacterium tuberculosis in high burden settings (English)

1 reference

Mycobacterium tuberculosis

5 September 2017

0 references

Tom A Yates

1

0 references

Jonathon G Taylor

object named as

Jonathon G Taylor

4

0 references

Gwenan M Knight

object named as

Gwenan M Knight

3

0 references

Robin Wood

10

object named as

Robin Wood

1 reference

5 September 2017

12

Ibrahim Abubakar

1 reference

5 September 2017

Palwasha Y Khan

2

1 reference

5 September 2017

Timothy D McHugh

5

1 reference

5 September 2017

Marc Lipman

6

1 reference

5 September 2017

Richard G White

7

1 reference

5 September 2017

Ted Cohen

8

1 reference

5 September 2017

Frank G Cobelens

9

1 reference

5 September 2017

David A J Moore

11

1 reference

5 September 2017

26 January 2016

1 reference

Lancet Infectious Diseases

5 September 2017

1 reference

5 September 2017

16

1 reference

5 September 2017

2

1 reference

5 September 2017

227-238

1 reference

Global epidemiology of tuberculosis

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

A tuberculin skin test survey among Ghanaian school children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

First national tuberculin survey in Viet Nam: characteristics and association with tuberculosis prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis control has failed in South Africa--time to reappraise strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Transmission of tuberculosis in a South African community with a high prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

A trial of mass isoniazid preventive therapy for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis vaccines and prevention of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Cough and the transmission of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The infectiousness of tuberculosis patients coinfected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis control and molecular epidemiology in a South African gold-mining community

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

A sign of superspreading in tuberculosis: highly skewed distribution of genotypic cluster sizes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Early clearance of Mycobacterium tuberculosis: a new frontier in prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The ongoing challenge of latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Timing of tuberculosis transmission and the impact of household contact tracing. An agent-based simulation model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Measuring tuberculosis burden, trends, and the impact of control programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Design of pragmatic trials of tuberculosis interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Design of pragmatic trials of tuberculosis interventions - authors' reply

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Annual risk of infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Randomised clinical trial investigating the specificity of a novel skin test (C-Tb) for diagnosis of M. tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Diagnosis of childhood tuberculosis and host RNA expression in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Social mixing patterns within a South African township community: implications for respiratory disease transmission and control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The impact of the HIV epidemic on tuberculosis transmission in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Bayesian inference of infectious disease transmission from whole-genome sequence data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Methodological problems in the molecular epidemiology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The detection of airborne Mycobacterium tuberculosis using micropore membrane air sampling and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Polymerase chain reaction used for the detection of airborne Mycobacterium tuberculosis in health care settings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Pilot study to detect airborne Mycobacterium tuberculosis exposure in a South African public healthcare facility outpatient clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Airborne spread of measles in a suburban elementary school

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Clearing the air. The theory and application of ultraviolet air disinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Airborne infection. Theoretical limits of protection achievable by building ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Risk of indoor airborne infection transmission estimated from carbon dioxide concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Quantification of shared air: a social and environmental determinant of airborne disease transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Role of ventilation in airborne transmission of infectious agents in the built environment - a multidisciplinary systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Hospital ventilation and risk for tuberculous infection in canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Natural ventilation for the prevention of airborne contagion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Wind-driven roof turbines: a novel way to improve ventilation for TB infection control in health facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Development of a numerical optimization approach to ventilation system design to control airborne contaminant dispersion and occupant comfort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Proportion of tuberculosis transmission that takes place in households in a high-incidence area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole Genome Sequencing Shows a Low Proportion of Tuberculosis Disease Is Attributable to Known Close Contacts in Rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis acquired outside of households, rural Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Tuberculosis transmission to young children in a South African community: modeling household and community infection risks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African township

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Pulmonary tuberculosis infection among workers in the informal public transport sector in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Will tuberculosis become resistant to all antibiotics?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Mathematical models of the epidemiology and control of drug-resistant TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The effect of drug resistance on the fitness of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Evolution and transmission of drug-resistant tuberculosis in a Russian population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

HIV infection and the transmission of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The impact of antiretroviral treatment programs on tuberculosis notification rates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Antiretroviral therapy for tuberculosis control in nine African countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900499-5

7 January 2021

10.1016/S1473-3099(15)00499-5

Identifiers

DOI

1 reference

5 September 2017

1 reference